Skip to Content

9 3 5215 (Hydrochlorothiazide and Moexipril Hydrochloride 25 mg / 15 mg)

Pill with imprint 9 3 5215 is Yellow, Capsule-shape and has been identified as Hydrochlorothiazide and Moexipril Hydrochloride 25 mg / 15 mg. It is supplied by Teva Pharmaceuticals USA.

Hydrochlorothiazide/moexipril is used in the treatment of high blood pressure and belongs to the drug class ACE inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/moexipril 25 mg / 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 9 3 5215

Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg 9 3 5215 Front
Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg 9 3 5215 Back
Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg 9 3 5215
Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg 9 3 5215
Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg 9 3 5215

Hydrochlorothiazide and Moexipril Hydrochloride

Imprint
9 3 5215
Strength
25 mg / 15 mg
Color
Yellow
Size
13.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Ace inhibitors with thiazides
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
Inactive Ingredients
lactose monohydrate, magnesium stearate, povidone k30, sodium bicarbonate, polyethylene glycol 3350, magnesium silicate, titanium dioxide, FD&C Red No. 40, FD&C Yellow No. 5, FD&C Yellow No. 6

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00093-5215 Teva Pharmaceuticals USA, Inc.
42291-0578 AvKare, Inc.
54868-3443 Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.